Arcus Biosciences (RCUS) Cash & Equivalents (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.46% |
| Dec 31, 2025 | -6.72% |
| Sep 30, 2025 | -4.03% |
| Jun 30, 2025 | 29.17% |
| Mar 31, 2025 | 28.00% |
| Dec 31, 2024 | -25.37% |
| Sep 30, 2024 | 28.85% |
| Jun 30, 2024 | -15.68% |
| Mar 31, 2024 | 45.67% |
| Dec 31, 2023 | -30.98% |
| Sep 30, 2023 | -20.00% |
| Jun 30, 2023 | -3.36% |
| Mar 31, 2023 | 15.53% |
| Dec 31, 2022 | -5.50% |
| Sep 30, 2022 | -20.15% |
| Jun 30, 2022 | -50.27% |
| Mar 31, 2022 | 270.95% |
| Dec 31, 2021 | -17.52% |
| Sep 30, 2021 | -44.01% |
| Jun 30, 2021 | -17.88% |
| Mar 31, 2021 | 125.04% |
| Dec 31, 2020 | -21.83% |
| Sep 30, 2020 | -22.21% |
| Jun 30, 2020 | 323.59% |
| Mar 31, 2020 | 16.21% |
| Dec 31, 2019 | -26.65% |
| Sep 30, 2019 | 3.84% |
| Jun 30, 2019 | 11.05% |
| Mar 31, 2019 | -3.61% |
| Dec 31, 2018 | -5.11% |
| Sep 30, 2018 | -55.95% |
| Jun 30, 2018 | -14.19% |
| Mar 31, 2018 | 101.28% |
| Dec 31, 2017 | 437.67% |
| Sep 30, 2017 | -38.20% |
| Jun 30, 2017 | -24.24% |
| Mar 31, 2017 | -40.00% |